Concepts (41)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2025 | 57 | 0.230 |
Why?
|
| RNA | 1 | 2025 | 527 | 0.180 |
Why?
|
| Metabolomics | 1 | 2025 | 457 | 0.180 |
Why?
|
| Breast Neoplasms | 2 | 2025 | 2588 | 0.150 |
Why?
|
| Transcriptome | 1 | 2025 | 1064 | 0.140 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2017 | 26 | 0.140 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2017 | 32 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2017 | 32 | 0.130 |
Why?
|
| Lung Neoplasms | 2 | 2025 | 1498 | 0.130 |
Why?
|
| Esophagus | 1 | 2017 | 229 | 0.120 |
Why?
|
| Skin | 1 | 2017 | 516 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 329 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 437 | 0.110 |
Why?
|
| Neoplasms | 1 | 2025 | 2841 | 0.080 |
Why?
|
| Phthalazines | 1 | 2017 | 14 | 0.030 |
Why?
|
| Organs at Risk | 1 | 2017 | 31 | 0.030 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2017 | 22 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 2017 | 54 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 189 | 0.030 |
Why?
|
| Diphosphonates | 1 | 2017 | 42 | 0.030 |
Why?
|
| ras Proteins | 1 | 2017 | 140 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 258 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2017 | 707 | 0.030 |
Why?
|
| Piperazines | 1 | 2017 | 251 | 0.030 |
Why?
|
| Antibodies | 1 | 2017 | 352 | 0.030 |
Why?
|
| Breast | 1 | 2017 | 209 | 0.030 |
Why?
|
| Imidazoles | 1 | 2017 | 218 | 0.030 |
Why?
|
| Epitopes | 1 | 2017 | 419 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 520 | 0.030 |
Why?
|
| DNA Damage | 1 | 2017 | 491 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 395 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1239 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 507 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 503 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2017 | 871 | 0.020 |
Why?
|
| Mice | 2 | 2017 | 17619 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 4517 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 4313 | 0.020 |
Why?
|
| Animals | 2 | 2017 | 33230 | 0.020 |
Why?
|
| Humans | 3 | 2025 | 126134 | 0.010 |
Why?
|
| Female | 2 | 2017 | 68037 | 0.010 |
Why?
|